Meir Goldsmith

发表

Nanoparticle hydrophobicity dictates immune response.

Dan Peer, Vincent M Rotello, V. Rotello, 2012, Journal of the American Chemical Society.

Precision nanomedicine in neurodegenerative diseases.

Dan Peer, D. Peer, Meir Goldsmith, 2014, ACS nano.

Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways.

T. Zor, M. Meijler, G. Levy-Rimler, 2009, Molecular immunology.

Comprehensive and Systematic Analysis of the Immunocompatibility of Polyelectrolyte Capsules.

U. Linne, C. Teodosio, D. Peer, 2017, Bioconjugate chemistry.

A modular platform for targeted RNAi therapeutics

J. Lieberman, D. Peer, M. Behlke, 2018, Nature Nanotechnology.

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies

J. Lieberman, D. Peer, Rafi Emmanuel, 2015, Proceedings of the National Academy of Sciences.

Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target.

E. Elinav, D. Peer, M. Behlke, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Conformation Sensitive Targeting of Lipid Nanoparticles for RNA Therapeutics

D. Peer, Meir Goldsmith, A. Packard, 2021, Nature Nanotechnology.

An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium

D. Peer, Y. Levy, M. Aftalion, 2022, bioRxiv.

A ceramide‐1‐phosphate analogue, PCERA‐1, simultaneously suppresses tumour necrosis factor‐α and induces interleukin‐10 production in activated macrophages

N. Gray, T. Zor, M. Meijler, 2009, Immunology.

Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.

N. Gray, T. Zor, M. Meijler, 2009, Immunology letters.

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes

Dan Peer, Daniel Rosenblum, Niels Dammes, 2018, Nature Communications.

Grand challenges in modulating the immune response with RNAi nanomedicines.

D. Peer, Meir Goldsmith, Shoshy Mizrahy, 2011, Nanomedicine.

Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.

Dan Peer, Biana Godin, D. Peer, 2014, Nanoscale.

Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles.

D. Peer, N. Muhanna, Meir Goldsmith, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Quantitative analysis of recombinant glucocerebrosidase brain delivery via lipid nanoparticles

D. Peer, M. Horowitz, Meir Goldsmith, 2018, Nano Futures.

The main challenge in the treatment of neurodegenerative diseases is to overcome the restrictive mechanism of the blood brain barrier and deliver therapeutic payloads to the brain . PERSPEC TIV E

D. Peer, Meir Goldsmith, L. Abramovitz, 2014 .

Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer.

D. Peer, M. S. Singh, Dalit Landesman-Milo, 2021, Small.

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

D. Peer, Y. Levy, M. Aftalion, 2023, Science advances.

Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer

D. Peer, Meir Goldsmith, Seok‐Beom Yong, 2022, Advanced materials.

Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach

Michael H. Shuman, D. Peer, M. Weil, 2011, Nanotechnology.

Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.

Dan Peer, D. Peer, N. Peshes-Yaloz, 2015, ACS nano.

Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles

D. Peer, I. Vaxman, Meir Goldsmith, 2023, Advanced science.

An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics.

Y. Barenholz, D. Peer, L. Kunz-Schughart, 2020, Nanoscale.

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery

D. Peer, Meir Goldsmith, Seok‐Beom Yong, 2023, Advanced science.

Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo

G. Angelini, D. Peer, F. Catapano, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.

Dan Peer, Biana Godin, D. Dykxhoorn, 2015, ACS nano.

Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells

D. Sprinzak, D. Peer, R. Zaidel-Bar, 2023, Science advances.

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies

J. Lieberman, D. Peer, Rafi Emmanuel, 2015, Proceedings of the National Academy of Sciences.

A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

T. Zor, C. Chalfant, M. Meijler, 2011, Immunology letters.

Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach

Michael H. Shuman, D. Peer, M. Weil, 2011, Nanotechnology.